microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s213026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

MicroRNA-511 Inhibits Malignant Behaviors of Breast Cancer by Directly Targeting SOX9 and Regulating the PI3K/Akt Pathway

International Journal of Oncology
Cancer ResearchOncology
2018English

MicroRNA‑448 Inhibits the Progression of Retinoblastoma by Directly Targeting ROCK1 and Regulating PI3K/AKT Signalling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

MicroRNA-145 Inhibits Growth of Laryngeal Squamous Cell Carcinoma by Targeting the PI3K/Akt Signaling Pathway

Cancer Management and Research
Oncology
2019English

MicroRNA‑766 Inhibits Papillary Thyroid Cancer Progression by Directly Targeting Insulin Receptor Substrate 2 and Regulating the PI3K/Akt Pathway

International Journal of Oncology
Cancer ResearchOncology
2018English

MicroRNA‑138 Suppresses Cell Proliferation and Invasion of Renal Cell Carcinoma by Directly Targeting SOX9

Oncology Letters
Cancer ResearchOncology
2017English

TLK2 Enhances Aggressive Phenotypes of Glioblastoma Cells Through the Activation of SRC Signaling Pathway

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

microRNA‑574 Inhibits Cell Proliferation and Invasion in Glioblastoma Multiforme by Directly Targeting Zinc Finger E‑box‑binding Homeobox 1

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

LIM and SH3 Protein 1 Regulates Cell Growth and Chemosensitivity of Human Glioblastoma via the PI3K/AKT Pathway

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy